These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17316816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Technology insight: therapeutic RNA interference--how far from the neurology clinic?
    Gonzalez-Alegre P, Paulson HL.
    Nat Clin Pract Neurol; 2007 Jul; 3(7):394-404. PubMed ID: 17611488
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Silencing neurodegenerative disease: bringing RNA interference to the clinic.
    Rodriguez-Lebron E, Gonzalez-Alegre P.
    Expert Rev Neurother; 2006 Feb; 6(2):223-33. PubMed ID: 16466302
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RNAi therapeutics for CNS disorders.
    Boudreau RL, Davidson BL.
    Brain Res; 2010 Jun 18; 1338():112-21. PubMed ID: 20307511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
    Federici T, Boulis NM.
    Neurosurgery; 2007 Jan 18; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y, Nishikawa M, Takakura Y.
    Adv Drug Deliv Rev; 2009 Jul 25; 61(9):760-6. PubMed ID: 19386274
    [Abstract] [Full Text] [Related]

  • 17. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R, Ghosh T, Scaria V, Pillai B.
    Drug Discov Today; 2009 Dec 25; 14(23-24):1123-9. PubMed ID: 19822222
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RNAi applications in therapy development for neurodegenerative disease.
    Maxwell MM.
    Curr Pharm Des; 2009 Dec 25; 15(34):3977-91. PubMed ID: 19751205
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.